PATENT CLAIM ANALYSIS

Application Number: 16138286
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "654000"]

Abstract:
The present invention is directed to pharmaceutical solution comprising at least dopamine for use in treating Parkinson's disease, wherein said pharmaceutical solution is kept under anaerobic conditions from its formulation to its administration.

Claim (Index 7):
The pharmaceutical solution for use according to  claim 1 , wherein said solution is administered with a predominant diurnal dose or with an exclusive diurnal dose.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 97.0
- Lexical Diversity: 1.16129
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15310364', '12384935', '11102521', '13647155', '09887854']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7650160875940168
- 35 USC 102 Novelty (BERT): 0.6081617878868968
- Combined Prediction Score: 0.7493306576233049
- Mean Citation Score: 364.717536
- Max Citation Score: 577.16754
- Similarity Product: 443.7006838251973

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test